Biofrontera Inc(BFRI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BFRI Biofrontera Inc

未开盘 07-23 16:00:00 EDT

1.09

+0.01

+0.93%

盘后1.09

+0.000.00%

19:44 EDT

最高1.09	最低1.05	成交量16.23万
今开1.07	昨收1.08	日振幅3.70%
总市值1,396万	流通市值989.72万	总股本1,280万
成交额17.35万	换手率1.79%	流通股本908.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BFRI","market":"US","secType":"STK","nameCN":"Biofrontera Inc","latestPrice":1.09,"timestamp":1784836800000,"preClose":1.08,"halted":0,"volume":162348,"hourTrading":{"tag":"盘后","latestPrice":1.09,"preClose":1.09,"latestTime":"19:44 EDT","volume":2960,"amount":3162.3229,"timestamp":1784850257038,"change":0,"changeRate":0,"amplitude":0.027248},"delay":0,"changeRate":0.009259259259259267,"floatShares":9080000,"shares":12803300,"eps":-1.019378,"marketStatus":"未开盘","change":0.01,"latestTime":"07-23 16:00:00 EDT","open":1.07,"high":1.09,"low":1.05,"amount":173464.1948472,"amplitude":0.037037,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.019378,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1784880000000},"marketStatusCode":0,"adr":0,"listingDate":1635480000000,"exchange":"NASDAQ","adjPreClose":1.08,"preHourTrading":{"tag":"盘前","latestPrice":1.06,"preClose":1.08,"latestTime":"09:12 EDT","volume":1253,"amount":1334.8399456,"timestamp":1784812377791,"change":-0.02,"changeRate":-0.018519,"amplitude":0.018519},"postHourTrading":{"tag":"盘后","latestPrice":1.09,"preClose":1.09,"latestTime":"19:44 EDT","volume":2960,"amount":3162.3229,"timestamp":1784850257038,"change":0,"changeRate":0,"amplitude":0.027248},"volumeRatio":0.952535,"impliedVol":4.5485,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/BFRI/wiki","defaultTab":"wiki","newsList":[{"id":"2635740909","title":"Biofrontera目标2026年实现现金流盈亏平衡 毛利率剑指80%-85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635740909","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635740909?lang=zh_cn&edition=full","pubTime":"2026-05-15 03:09","pubTimestamp":1778785740,"startTime":"0","endTime":"0","summary":"　　Biofrontera近日公布2026年第一季度财报。数据显示，公司一季度产品营收达1010万美元，同比增长17%，主要得益于Ameluz单位销量约16%的增长及2025年第四季度的提价效应。根据新协议，公司向Biofrontera AG支付净销售额12%至15%的特许权使用费，取代了此前25%至35%的转让定价模式。公司重申2026年全年毛利率目标为80%至85%。截至2026年3月31日，公司持有现金及现金等价物约630万美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-15/doc-inhxwzrz3712233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BFRI","159399","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155586230","title":"Biofrontera Inc公布积极二期B阶段结果 支持Ameluz®光动力疗法针对中重度痤疮的进一步开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1155586230","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155586230?lang=zh_cn&edition=full","pubTime":"2026-03-09 21:15","pubTimestamp":1773062116,"startTime":"0","endTime":"0","summary":"Biofrontera Inc宣布其Ameluz®光动力疗法在治疗中重度寻常型痤疮的二期B阶段临床试验中取得积极结果。该结果有力支持该疗法的后续研发推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BFRI","BFRIW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617557423","title":"Biofrontera Inc.盘中异动 股价大跌5.13%报0.850美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617557423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617557423?lang=zh_cn&edition=full","pubTime":"2026-03-06 02:49","pubTimestamp":1772736556,"startTime":"0","endTime":"0","summary":"北京时间2026年03月06日02时49分，Biofrontera Inc.股票出现异动，股价快速下跌5.13%。截至发稿，该股报0.850美元/股，成交量1.629万股，换手率0.14%，振幅4.02%。Biofrontera Inc.股票所在的制药行业中，整体跌幅为2.58%。Biofrontera Inc.公司简介：Biofrontera Inc 是一家总部位于美国的生物制药公司，专注于商业化一系列用于治疗皮肤科疾病的药物产品，特别关注光动力疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603060249179543335c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603060249179543335c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BFRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616269302","title":"Biofrontera Inc.盘中异动 股价大跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616269302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616269302?lang=zh_cn&edition=full","pubTime":"2026-03-04 00:42","pubTimestamp":1772556171,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日00时42分，Biofrontera Inc.股票出现波动，股价大幅跳水5.82%。截至发稿，该股报0.870美元/股，成交量4.2728万股，换手率0.37%，振幅2.27%。Biofrontera Inc.股票所在的制药行业中，整体跌幅为1.77%。Biofrontera Inc.公司简介：Biofrontera Inc 是一家总部位于美国的生物制药公司，专注于商业化一系列用于治疗皮肤科疾病的药物产品，特别关注光动力疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304004251a4477af8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304004251a4477af8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BFRI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614897403","title":"Biofrontera Inc.盘中异动 早盘股价大跌5.05%报0.880美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614897403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614897403?lang=zh_cn&edition=full","pubTime":"2026-02-27 22:32","pubTimestamp":1772202765,"startTime":"0","endTime":"0","summary":"北京时间2026年02月27日22时32分，Biofrontera Inc.股票出现波动，股价大幅下跌5.05%。截至发稿，该股报0.880美元/股，成交量4426股，换手率0.04%，振幅0.00%。Biofrontera Inc.股票所在的制药行业中，整体涨幅为0.39%。Biofrontera Inc.公司简介：Biofrontera Inc 是一家总部位于美国的生物制药公司，专注于商业化一系列用于治疗皮肤科疾病的药物产品，特别关注光动力疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227223245a437c164&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227223245a437c164&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BFRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109600264","title":"美国专利商标局终裁决定：太阳药业专利11,697,028全部被异议权利要求均不具备可专利性","url":"https://stock-news.laohu8.com/highlight/detail?id=1109600264","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109600264?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:20","pubTimestamp":1772115639,"startTime":"0","endTime":"0","summary":"美国专利商标局（USPTO）已就太阳药业持有的第11,697,028号专利发布最终书面决定。该决定认定，针对此项专利所提出的全部被异议权利要求，均不具备可专利性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BFRI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180429435","title":"Biofrontera Inc 预计于2026年第三季度提交四肢、颈部和躯干适应症的补充新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1180429435","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180429435?lang=zh_cn&edition=full","pubTime":"2026-02-17 22:16","pubTimestamp":1771337802,"startTime":"0","endTime":"0","summary":"Biofrontera Inc 计划在2026年第三季度向监管机构提交一份补充新药申请（sNDA），该申请针对的是其在四肢、颈部和躯干方面的适应症扩展。此举标志着公司在拓展其产品应用范围方面迈出了重要一步，有望为相关患者群体提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BFRI","BFRIW","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184834707","title":"Biofrontera Inc宣布完成用于躯干及四肢光化性角化病的Ameluz®一期药代动力学研究数据库锁定","url":"https://stock-news.laohu8.com/highlight/detail?id=1184834707","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184834707?lang=zh_cn&edition=full","pubTime":"2026-02-17 22:15","pubTimestamp":1771337729,"startTime":"0","endTime":"0","summary":"Biofrontera Inc（纳斯达克代码：BFRI）近日宣布，其针对躯干及四肢光化性角化病的Ameluz®药物一期药代动力学研究已完成数据库锁定。这一关键步骤标志着该临床试验数据收集阶段的正式结束，为后续的数据分析和结果评估奠定了坚实基础。公司表示，此项研究的推进将进一步丰富Ameluz®在皮肤疾病治疗领域的临床应用数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BFRIW","BFRI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161002689","title":"Biofrontera宣布FDA受理Ameluz®光动力疗法治疗浅表基底细胞癌的补充新药申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1161002689","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161002689?lang=zh_cn&edition=full","pubTime":"2026-02-11 22:16","pubTimestamp":1770819389,"startTime":"0","endTime":"0","summary":"Biofrontera Inc（简称Biofrontera）近日宣布，美国食品药品监督管理局（FDA）已正式受理其针对Ameluz®光动力疗法（PDT）用于治疗浅表基底细胞癌（sBCC）的补充新药申请（sNDA）。这一重要进展标志着该药物在拓展适应症方面迈出了关键一步，为患者提供了潜在的新治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BFRIW","BFRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179752893","title":"Biofrontera公布Ameluz®光动力疗法治疗四肢、颈部和躯干光化性角化病三期研究积极结果，达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1179752893","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179752893?lang=zh_cn&edition=full","pubTime":"2026-02-09 22:16","pubTimestamp":1770646572,"startTime":"0","endTime":"0","summary":"Biofrontera Inc (NASDAQ: BFRI) 宣布，其用于治疗四肢、颈部和躯干光化性角化病的Ameluz®光动力疗法在三期临床研究中取得积极结果，成功达到了主要研究终点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BFRIW","BK4007","BFRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178821331","title":"Biofrontera Inc公布2025年第四季度初步营收创纪录，达1700万至1750万美元，同比增长约35%","url":"https://stock-news.laohu8.com/highlight/detail?id=1178821331","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178821331?lang=zh_cn&edition=full","pubTime":"2026-01-13 21:33","pubTimestamp":1768311214,"startTime":"0","endTime":"0","summary":"Biofrontera Inc披露了2025财年第四季度的初步营收数据，预计将录得1700万美元至1750万美元的创纪录业绩，较去年同期实现约35%的显著增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BFRI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518272506","title":"Biofrontera Inc.盘中异动 早盘快速上涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518272506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518272506?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:49","pubTimestamp":1741614561,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时49分，Biofrontera Inc.股票出现异动，股价快速上涨5.24%。Biofrontera Inc.股票所在的制药行业中，整体跌幅为1.21%。其相关个股中，Sonoma Pharmaceuticals, Inc.、Sunshine Biopharma Inc C/Wts 、Scilex Holding Company涨幅较大，Sonoma Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为270.64%、11.78%、6.83%，振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、Sonoma Pharmaceuticals, Inc.、苏轩堂，振幅分别为35.91%、31.15%、22.26%。Biofrontera Inc.公司简介：Biofrontera Inc 是一家总部位于美国的生物制药公司，将用于治疗皮肤病的药品组合商业化，重点关注光动力疗法  和外用抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214921abf30318&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214921abf30318&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BFRI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517607324","title":"Biofrontera Inc.盘中异动 股价大跌6.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517607324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517607324?lang=zh_cn&edition=full","pubTime":"2025-03-05 02:17","pubTimestamp":1741112258,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日02时17分，Biofrontera Inc.股票出现异动，股价急速下挫6.23%。Biofrontera Inc.股票所在的制药行业中，整体跌幅为1.09%。Biofrontera Inc.公司简介：Biofrontera Inc 是一家总部位于美国的生物制药公司，将用于治疗皮肤病的药品组合商业化，重点关注光动力疗法  和外用抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305021739989be292&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305021739989be292&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BFRI","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516654535","title":"Biofrontera Inc.盘中异动 大幅跳水5.67%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516654535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516654535?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:10","pubTimestamp":1741025415,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时10分，Biofrontera Inc.股票出现波动，股价急速下挫5.67%。截至发稿，该股报0.920美元/股，成交量3.3921万股，换手率0.38%，振幅3.73%。Biofrontera Inc.股票所在的制药行业中，整体涨幅为1.15%。Biofrontera Inc.公司简介：Biofrontera Inc 是一家总部位于美国的生物制药公司，将用于治疗皮肤病的药品组合商业化，重点关注光动力疗法  和外用抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021015989a41b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021015989a41b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BFRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514286235","title":"Biofrontera Inc.盘中异动 下午盘大幅下挫6.34%报1.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514286235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514286235?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:09","pubTimestamp":1740600576,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时09分，Biofrontera Inc.股票出现异动，股价大幅下挫6.34%。截至发稿，该股报1.03美元/股，成交量9.6709万股，换手率1.09%，振幅6.36%。Biofrontera Inc.股票所在的制药行业中，整体跌幅为0.28%。Biofrontera Inc.公司简介：Biofrontera Inc 是一家总部位于美国的生物制药公司，将用于治疗皮肤病的药品组合商业化，重点关注光动力疗法  和外用抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022704093696318b18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022704093696318b18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BFRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514201298","title":"美国OTC市场Ono Pharmaceutical Co盘中异动 临近午盘急速拉升5.07%报3.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514201298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514201298?lang=zh_cn&edition=full","pubTime":"2025-02-26 01:15","pubTimestamp":1740503705,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日01时15分，美国OTC市场Ono Pharmaceutical Co股票出现波动，股价大幅拉升5.07%。截至发稿，该股报3.56美元/股，成交量11.219万股，换手率0.01%，振幅1.47%。美国OTC市场Ono Pharmaceutical Co股票所在的制药行业中，整体涨幅为1.39%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Biofrontera Inc C/Wts 27/10/2026 、Talphera, Inc.涨幅较大，Petros Pharmaceuticals, Inc.、Redhill Biopharma Ltd、苏轩堂较为活跃，换手率分别为178.01%、175.18%、111.88%，振幅较大的相关个股有Redhill Biopharma Ltd、Biofrontera Inc C/Wts 27/10/2026 、Sunshine Biopharma Inc C/Wts ，振幅分别为56.85%、49.75%、43.75%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022601150596301421&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022601150596301421&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OPHLY","BFRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514779533","title":"Citius Oncology, Inc.盘中异动 临近午盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514779533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514779533?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:44","pubTimestamp":1740415450,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时44分，Citius Oncology, Inc.股票出现波动，股价急速拉升5.13%。截至发稿，该股报1.23美元/股，成交量7.8856万股，换手率0.11%，振幅3.42%。Citius Oncology, Inc.股票所在的制药行业中，整体涨幅为1.10%。Citius Oncology, Inc.公司简介：Citius Oncology Inc 是一家专业制药公司，致力于针对肿瘤产品未满足需求的重症护理产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225004411a25232c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225004411a25232c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTOR","BK4007","BFRI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514932776","title":"Evoke Pharma, Inc.盘中异动 急速跳水7.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514932776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514932776?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:28","pubTimestamp":1740414481,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时28分，Evoke Pharma, Inc.股票出现波动，股价急速跳水7.30%。Evoke Pharma, Inc.股票所在的制药行业中，整体涨幅为0.82%。其相关个股中，Sunshine Biopharma Inc C/Wts 、Biofrontera Inc C/Wts 27/10/2026 、Amneal Pharmaceuticals, Inc.涨幅较大，大自然药业、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为41.96%、30.40%、9.38%，振幅较大的相关个股有Sunshine Biopharma Inc C/Wts 、Biofrontera Inc C/Wts 27/10/2026 、Cyclo Therapeutics Inc C/Wts 11/12/2025，振幅分别为82.00%、69.09%、41.56%。Evoke Pharma, Inc.公司简介：Evoke Pharma Inc 是一家专业制药公司，专注于治疗胃肠道疾病的药物的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225002802a2522f48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225002802a2522f48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BFRI","EVOK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513833727","title":"Optinose, Inc.盘中异动 早盘股价大涨7.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513833727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513833727?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:35","pubTimestamp":1740407725,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时35分，Optinose, Inc.股票出现波动，股价大幅拉升7.97%。Optinose, Inc.股票所在的制药行业中，整体涨幅为0.47%。其相关个股中，Biofrontera Inc C/Wts 27/10/2026 、Talphera, Inc.、Amneal Pharmaceuticals, Inc.涨幅较大，大自然药业、Petros Pharmaceuticals, Inc.、Therapeuticsmd, Inc.较为活跃，换手率分别为31.58%、5.22%、1.21%，振幅较大的相关个股有Biofrontera Inc C/Wts 27/10/2026 、Talphera, Inc.、Quantum Biopharma Ltd.，振幅分别为17.64%、9.98%、8.51%。Optinose, Inc.公司简介：OptiNose Inc 是一家专业制药公司，专注于为耳鼻喉科患者和过敏专家提供的产品的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223525abdb0ecc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223525abdb0ecc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","OPTN","BFRI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727960","title":"Talphera, Inc.盘中异动 早盘股价大涨6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727960?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:31","pubTimestamp":1740407503,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时31分，Talphera, Inc.股票出现波动，股价快速拉升6.56%。Talphera, Inc.股票所在的制药行业中，整体涨幅为0.20%。其相关个股中，Biofrontera Inc C/Wts 27/10/2026 、Amneal Pharmaceuticals, Inc.、Flora Growth Corp.涨幅较大，大自然药业、Petros Pharmaceuticals, Inc.、Therapeuticsmd, Inc.较为活跃，换手率分别为29.02%、4.79%、0.90%，振幅较大的相关个股有Biofrontera Inc C/Wts 27/10/2026 、大自然药业、坎伯兰药业，振幅分别为17.64%、4.92%、4.80%。Talphera, Inc.公司简介：Talphera Inc. 是一家制药公司，专注于在医疗监督环境中使用的疗法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242231449890f58f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242231449890f58f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BFRI","BK4007","TLPH","UPC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biofrontera-us.com","stockEarnings":[{"period":"1week","weight":-0.018},{"period":"1month","weight":0.0583},{"period":"3month","weight":0.0093},{"period":"6month","weight":0.09},{"period":"1year","weight":0.0093},{"period":"ytd","weight":0.9123}],"compareEarnings":[{"period":"1week","weight":-0.0167},{"period":"1month","weight":0.0063},{"period":"3month","weight":0.034},{"period":"6month","weight":0.071},{"period":"1year","weight":0.1639},{"period":"ytd","weight":0.0825}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Biofrontera Inc.于2015年3月在特拉华州注册成立。该公司是一家总部位于美国的生物制药公司，专门从事用于治疗皮肤病的药物产品的商业化，特别是主要由暴露在阳光下导致皮肤受到阳光伤害的疾病。该公司的许可产品专注于治疗光化性角化病，这是一种有时会导致皮肤癌的皮肤病变。该公司还销售一种用于治疗脓疱病（一种细菌性皮肤感染）的局部抗生素。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.094627},{"month":2,"riseRate":0,"avgChangeRate":-0.157137},{"month":3,"riseRate":0.4,"avgChangeRate":0.099754},{"month":4,"riseRate":0.6,"avgChangeRate":0.096622},{"month":5,"riseRate":0,"avgChangeRate":-0.248941},{"month":6,"riseRate":0.6,"avgChangeRate":-0.008104},{"month":7,"riseRate":0.8,"avgChangeRate":0.180921},{"month":8,"riseRate":0,"avgChangeRate":-0.180573},{"month":9,"riseRate":0.75,"avgChangeRate":0.062418},{"month":10,"riseRate":0.5,"avgChangeRate":-0.098487},{"month":11,"riseRate":0.2,"avgChangeRate":-0.09664},{"month":12,"riseRate":0.4,"avgChangeRate":-0.026989}],"exchange":"NASDAQ","name":"Biofrontera Inc","nameEN":"Biofrontera Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biofrontera Inc(BFRI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Biofrontera Inc(BFRI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Biofrontera Inc,BFRI,Biofrontera Inc股票,Biofrontera Inc股票老虎,Biofrontera Inc股票老虎国际,Biofrontera Inc行情,Biofrontera Inc股票行情,Biofrontera Inc股价,Biofrontera Inc股市,Biofrontera Inc股票价格,Biofrontera Inc股票交易,Biofrontera Inc股票购买,Biofrontera Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biofrontera Inc(BFRI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Biofrontera Inc(BFRI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}